Phase 1 Advanced Malignancies Clinical Trials
8 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–8 of 8 trials
Recruiting
Phase 1Phase 2
BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)
Ovarian CancerMelanomaT-cell Lymphoma+1 more
BioInvent International AB176 enrolled25 locationsNCT04752826
Recruiting
Phase 1
Study to Assess Safety, Tolerability and Activity of DSB2455 in Participants With Advanced Malignancies
Advanced Malignancies With Homologous Recombination Deficiency (HRD) (Breast, Ovarian, mCRPC, Brain Metastases)
Duke Street Bio Ltd90 enrolled13 locationsNCT06458712
Recruiting
Phase 1
A Study of BRY812 for Injection Alone in Subjects With Advanced Malignancies
Advanced Malignancies
BioRay Pharmaceutical Co., Ltd.164 enrolled1 locationNCT06038058
Recruiting
Phase 1
A Study of BR111 in Patients With Advanced Malignancies
Advanced Malignancies
BioRay Pharmaceutical Co., Ltd.166 enrolled1 locationNCT06937957
Recruiting
Phase 1
A Study of IBI363 in Combination With Bevacizumab or Furuitinib in Subjects With Advanced Colorectal Cancer
Advanced Malignancies
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology260 enrolled1 locationNCT06717880
Recruiting
Phase 1
A Clinical Study of MIL95 in Advanced Malignancies.
Advanced Malignancies
Beijing Mabworks Biotech Co., Ltd.58 enrolled1 locationNCT04651348
Recruiting
Phase 1
A Study of IBI363 in Subjects With Advanced Malignancies
Advanced Malignancies
Innovent Biologics (Suzhou) Co. Ltd.556 enrolled1 locationNCT06468098
Recruiting
Phase 1Phase 2
A Study of TQB2930 for Injection Monotherapy or Combination Therapy in Patients With Recurrent/Metastatic Breast Cancer
Metastatic Breast CancerRecurrent Breast CancerAdvanced Malignancies
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.154 enrolled2 locationsNCT06202261